Fulgent Genetics, Inc. Form 4 — BOLGER JOHN C (March 1, 2022)

Summary

BOLGER JOHN C, a director of Fulgent Genetics, Inc., reports on this Form 4 Stock Option (Right to Buy) exercises on 03/01/2022 of 625 shares at each of the exercise prices $3.925, $5.8098 and $15.82. Each exercise was followed the same day by a sale of 625 shares, at $61.4202, $61.402 and $61.2681, and 2,000 shares were owned directly after each sale. The first sale price is a weighted average from transactions at prices ranging from $61.0767 to $61.4400, inclusive. After the exercises the options covered 313, 1,563 and 2,813 shares, expiring 05/18/2028, 05/30/2029 and 05/26/2030; the remarks show /s/ Paul Kim, as Attorney-in-fact, dated 03/03/2022.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * BOLGER JOHN C (Last) (First) (Middle) C/O FULGENT GENETICS, INC. 4978 SANTA ANITA AVE. (Street) TEMPLE CITY CA 91780 (City) (State) (Zip) | BOLGER JOHN C | (Last) | (First) | (Middle) | C/O FULGENT GENETICS, INC. | 4978 SANTA ANITA AVE. | TEMPLE CITY | CA | 91780 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Fulgent Genetics, Inc. [ FLGT ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below) | X | Director | 10% Owner | Officer (give title below) | Other (specify below)
3. Date of Earliest Transaction
 (Month/Day/Year) 03/01/2022
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 03/01/2022 | M | 625 | A | $ 3.925 | 2,625 | D
Common Stock | 03/01/2022 | S | 625 | D | $ 61.4202 (1) | 2,000 | D
Common Stock | 03/01/2022 | M | 625 | A | $ 5.8098 | 2,625 | D
Common Stock | 03/01/2022 | S | 625 | D | $ 61.402 | 2,000 | D
Common Stock | 03/01/2022 | M | 625 | A | $ 15.82 | 2,625 | D
Common Stock | 03/01/2022 | S | 625 | D | $ 61.2681 | 2,000 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Stock Option (Right to Buy) | $ 3.925 | 03/01/2022 | M | 625 | (2) | 05/18/2028 | Common Stock | 625 | $ 0.00 | 313 | D
Stock Option (Right to Buy) | $ 5.8098 | 03/01/2022 | M | 625 | (3) | 05/30/2029 | Common Stock | 625 | $ 0.00 | 1,563 | D
Stock Option (Right to Buy) | $ 15.82 | 03/01/2022 | M | 625 | (4) | 05/26/2030 | Common Stock | 625 | $ 0.00 | 2,813 | D
Explanation of Responses:
1. The shares were sold in multiple transactions at prices ranging from $61.0767 to $61.4400, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
2. The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
3. The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
4. The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
Remarks:
/s/ Paul Kim, as Attorney-in-fact | 03/03/2022
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_FLGT_4_filed2022-03-03_0001209191-22-015590.xml

Size

22,875 bytes

SHA-256

e9a31a128895a06b78a1eb691b54057bed62f9a7112549f4855be165878e1744

Our copy

SEC_FLGT_4_filed2022-03-03_0001209191-22-015590.xml

Original

www.sec.gov